(firstQuint)Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients.

 In a randomized clinical trial study, 80 obese women with BMI30, oligomenorrhae, hirsutism and presence of > 12 ovarian follicles (2-10mm diameter), were evaluated.

 In metformin group , metformin was administered for patients 1500 mg daily for three months.

 In orlistate group, patients used orlistat tablets (120 mg, 3 times a day) for three months.

 BMI, serum LH and FSH levels, serum triglyceride and cholesterol levels and also patients' ovulation was compared before and after treatment.

.

 Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients@highlight

The purpose of this study is to compare the influence of Orlistat and Metformin on obesity treatment in obese PCOS women.

